CAW
AZN icon

Cornerstone Advisors (Washington)’s AstraZeneca AZN Stock Holding History

Cornerstone Advisors (Washington)’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-974
Closed -$80K – 867
2019
Q2 		$80K Buy
974
+207
+27% +$16.2K 0.01% 291
2019
Q1 		$62K Buy
767
+291
+61% +$22.9K 0.01% 307
2018
Q4 		$36K Buy
476
+105
+28% +$8.2K 0.01% 368
2018
Q3 		$29K Buy
371
+80
+27% +$6.05K 0.02% 451
2018
Q2 		$20K Buy
291
+122
+72% +$8.78K 0.01% 500
2018
Q1 		$12K Buy
169
+80
+90% +$5.54K 0.01% 561
2017
Q4 		$6K Hold
89
– – ﹤0.01% 658
2017
Q3 		$6K Sell
89
-94
-51% -$5.94K ﹤0.01% 656
2017
Q2 		$12K Buy
183
+94
+106% +$6.14K 0.01% 555
2017
Q1 		$6K Hold
89
– – ﹤0.01% 660
2016
Q4 		$5K Sell
89
-420
-83% -$23.8K ﹤0.01% 697
2016
Q3 		$33K Hold
509
– – 0.03% 330
2016
Q2 		$31K Buy
509
+62
+14% +$3.6K 0.03% 211
2016
Q1 		$25K Sell
447
-70
-14% -$4.21K 0.03% 248
2015
Q4 		$35K Sell
517
-202
-28% -$13.2K 0.04% 230
2015
Q3 		$46K Buy
719
+46
+7% +$3.03K 0.04% 187
2015
Q2 		$43K Buy
673
+24
+4% +$1.64K 0.04% 179
2015
Q1 		$44K Buy
649
+145
+29% +$10.1K 0.03% 199
2014
Q4 		$35K Buy
504
+57
+13% +$4.08K 0.03% 214
2014
Q3 		$32K Hold
447
– – 0.03% 99
2014
Q2 		$33K Sell
447
-12
-3% -$867 0.03% 108
2014
Q1 		$30K Buy
459
+18
+4% +$1.16K 0.04% 106
2013
Q4 		$26K Hold
441
– – 0.04% 92
2013
Q3 		$23K Hold
441
– – 0.04% 95
2013
Q2 		$21K Buy
+441
New +$22.5K 0.05% 52

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Cornerstone Advisors (Washington)'s AZN Position: Q3 2019 in Review

Cornerstone Advisors (Washington) sold out of AstraZeneca (AZN) in Q3 2019, closing a stake of 974 shares — an estimated $80K sold.

Cornerstone Advisors (Washington) first reported a position in AZN in Q2 2013 and held it in 25 quarters. The position peaked at $80K in Q2 2019. 555 funds tracked by Wall St. Rank hold AZN as of Q3 2019.

  • Cornerstone Advisors (Washington) reported no remaining AstraZeneca position as of Q3 2019 after selling out during the quarter.
  • Cornerstone Advisors (Washington) sold 974 AstraZeneca shares in Q3 2019, an estimated $80K.
  • Cornerstone Advisors (Washington) first reported a position in AstraZeneca in Q2 2013 and held it in 25 quarters.
  • Cornerstone Advisors (Washington)'s AstraZeneca position peaked at $80K in Q2 2019.
  • 555 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2019.

Based on Cornerstone Advisors (Washington)'s 13F filing for Q3 2019, filed 23 Oct 2019.